Total Payments
$1,510
2024 Payments
$101.21
Companies
26
Transactions
92
Medicare Patients
11,708
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$1,428 (94.6%)
Education$81.99 (5.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,428 | 89 | 94.6% |
| Education | $81.99 | 3 | 5.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $149.40 | 10 | $0 (2023) |
| GlaxoSmithKline, LLC. | $144.65 | 8 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $104.20 | 7 | $0 (2023) |
| OPKO Pharmaceuticals, LLC | $99.20 | 7 | $0 (2021) |
| Vifor Pharma, Inc. | $98.78 | 6 | $0 (2022) |
| Amgen Inc. | $96.24 | 6 | $0 (2024) |
| Horizon Pharma plc | $94.02 | 5 | $0 (2018) |
| Alexion Pharmaceuticals, Inc. | $91.88 | 4 | $0 (2023) |
| Genentech USA, Inc. | $65.27 | 4 | $0 (2018) |
| Relypsa, Inc. | $54.12 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $101.21 | 6 | Novartis Pharmaceuticals Corporation ($47.39) |
| 2023 | $127.72 | 8 | Horizon Therapeutics plc ($42.38) |
| 2022 | $314.75 | 18 | Horizon Therapeutics plc ($79.41) |
| 2021 | $461.34 | 29 | GlaxoSmithKline, LLC. ($87.81) |
| 2020 | $86.01 | 5 | Relypsa, Inc. ($35.36) |
| 2018 | $192.03 | 12 | Genentech USA, Inc. ($65.27) |
| 2017 | $227.05 | 14 | OPKO Pharmaceuticals, LLC ($46.14) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/29/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Immunology | ||||||
| 08/05/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Diabetes | ||||||
| 04/09/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $16.62 | General |
| 01/30/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Inflammation/Rare Disease | ||||||
| 01/25/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 01/11/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $15.37 | General |
| 11/24/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Rare Disease | ||||||
| 11/09/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: KRYSTEXXA | ||||||
| 11/06/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/05/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/04/2023 | GlaxoSmithKline, LLC. | JESDUVROQ (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: NEPHROLOGY | ||||||
| 06/08/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $10.79 | General |
| 04/19/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: KRYSTEXXA | ||||||
| 02/27/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: KRYSTEXXA | ||||||
| 11/22/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Cardio-renal | ||||||
| 10/31/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: KRYSTEXXA | ||||||
| 09/26/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: KRYSTEXXA | ||||||
| 08/17/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: KRYSTEXXA | ||||||
| 05/23/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: KRYSTEXXA | ||||||
| 05/12/2022 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Hyperkalemia | ||||||
| 05/07/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/27/2022 | Alexion Pharmaceuticals, Inc. | — | Education | In-kind items and services | $45.41 | General |
| 04/25/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: KRYSTEXXA | ||||||
| 04/19/2022 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Genetic Disease | ||||||
| 04/18/2022 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Nephrology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 3,339 | 6,313 | $640,537 | $335,212 |
| 2022 | 21 | 3,001 | 6,029 | $642,506 | $338,754 |
| 2021 | 23 | 2,450 | 12,929 | $724,995 | $393,851 |
| 2020 | 29 | 2,918 | 26,674 | $832,554 | $398,641 |
Total Patients
11,708
Total Services
51,945
Medicare Billing
$1.5M
Procedure Codes
96
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 77 | 482 | $202,440 | $125,136 | 61.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 512 | 894 | $116,220 | $76,571 | 65.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 150 | 483 | $43,470 | $27,636 | 63.6% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 16 | 91 | $38,220 | $19,034 | 49.8% |
| 80047 | Blood test, basic group of blood chemicals (calcium, ionized) | Office | 2023 | 504 | 885 | $38,055 | $11,697 | 30.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 105 | 119 | $29,750 | $11,326 | 38.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 84 | 84 | $21,420 | $9,605 | 44.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 66 | 183 | $45,750 | $9,292 | 20.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 505 | 887 | $13,305 | $7,342 | 55.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 20 | 25 | $7,875 | $5,542 | 70.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 32 | 65 | $8,775 | $5,510 | 62.8% |
| G0407 | Follow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth | Office | 2023 | 34 | 96 | $20,160 | $5,141 | 25.5% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 83 | 84 | $10,752 | $4,126 | 38.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 67 | $5,360 | $3,904 | 72.8% |
| 85014 | Red blood cell concentration measurement | Office | 2023 | 504 | 885 | $4,425 | $2,016 | 45.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 517 | 863 | $8,630 | $1,859 | 21.5% |
| G0426 | Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth | Office | 2023 | 13 | 19 | $7,600 | $1,840 | 24.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 16 | $4,320 | $1,755 | 40.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 12 | $3,000 | $1,563 | 52.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 17 | 24 | $2,400 | $1,470 | 61.3% |
| 90937 | Hemodialysis procedure requiring repeated evaluation | Facility | 2023 | 16 | 20 | $5,700 | $1,368 | 24.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $1,650 | $819.00 | 49.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 14 | 18 | $1,260 | $661.14 | 52.5% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 74 | 523 | $219,660 | $135,801 | 61.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 523 | 961 | $124,930 | $80,764 | 64.6% |
About Dr. Kendra Hendon, M.D
Dr. Kendra Hendon, M.D is a Nephrology healthcare provider based in Knoxville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1538169305.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kendra Hendon, M.D has received a total of $1,510 in payments from pharmaceutical and medical device companies, with $101.21 received in 2024. These payments were reported across 92 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($1,428).
As a Medicare-enrolled provider, Hendon has provided services to 11,708 Medicare beneficiaries, totaling 51,945 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Knoxville, TN
- Active Since 07/22/2005
- Last Updated 08/28/2013
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1538169305
Products in Payments
- KRYSTEXXA (Biological) $163.06
- Veltassa (Drug) $152.90
- BENLYSTA (Biological) $121.08
- KRYSTEXXA (Drug) $94.02
- Parsabiv (Drug) $82.58
- ACTHAR (Biological) $71.54
- Rituxan (Biological) $65.27
- Rayaldee (Drug) $60.41
- LOKELMA (Drug) $59.67
- INJECTAFER (Drug) $53.83
- Auryxia (Drug) $45.40
- FARXIGA (Drug) $44.53
- RAYALDEE (Drug) $38.79
- ULTOMIRIS (Biological) $31.76
- Kerendia (Drug) $30.40
- CLEVIPREX (Drug) $29.02
- GATTEX (Drug) $26.70
- SAMSCA (Drug) $23.82
- JESDUVROQ (Drug) $23.57
- JARDIANCE (Drug) $23.27
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Knoxville
Gerald Borrelli, M.d, M.D
Nephrology — Payments: $252,660
Nephrology $252,660
Urath Suresh, Md, MD
Nephrology — Payments: $12,565
Nephrology $12,565
Denise Rivers, Do, DO
Nephrology — Payments: $8,727
Nephrology $8,727
Kaitlin Desrosiers, Fnp-C, FNP-C
Nephrology — Payments: $4,862
Nephrology $4,862
Jimmy Gentry, M.d, M.D
Nephrology — Payments: $2,486
Nephrology $2,486
Asif Sultan, M.d, M.D
Nephrology — Payments: $1,234
Nephrology $1,234